Cayuga Biotech: Funding, Investors & Team (Oct 2026)
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
Cayuga Biotech has raised $5.0M across 1 funding round on record, the most recent a Seed of $5.0M announced in Dec 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cayuga Biotech Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Cayuga Biotech Funding Rounds
Cayuga Biotech Founders and Leadership Team
Contact details for the Cayuga Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Cayuga Biotech Funding Compared to Other Biotechnology Startups
Cayuga Biotech's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cayuga Biotech in Biotechnology and Bridgewater
Companies Similar to Cayuga Biotech
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Cayuga Biotech Funding FAQs
What does Cayuga Biotech do?
Cayuga Biotech is a startup developing novel hemostatic drugs and devices to reduce uncontrollable bleeding which is a leading cause of death from traumatic injuries. The company's polyphosphate-based drug accelerates the body's own clotting process to contain clotting at the injury site and thus minimize the risk of side effects. Cayuga is developing drugs for indications that treat traumatic hemorrhage as well as rare bleeding disorders.
How much funding has Cayuga Biotech raised?
Cayuga Biotech has raised $5.0M across 1 round on record. The most recent is a Seed of $5.0M announced in Dec 2025.
When did Cayuga Biotech last raise funding?
Cayuga Biotech's most recent funding round on record is a Seed of $5.0M, announced in Dec 2025.
Who founded Cayuga Biotech?
FundedIQ lists Damien Kudela (Founder) at Cayuga Biotech.
Where is Cayuga Biotech headquartered?
Cayuga Biotech is based in Bridgewater, New Jersey, United States.
How many employees does Cayuga Biotech have?
Cayuga Biotech is in the 11-50 employee band.
How does Cayuga Biotech's funding compare to other Biotechnology startups?
Cayuga Biotech's latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Cayuga Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cayuga Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.